الرئيسية › السمنة › تكساس › Houston
التجارب السريرية لـ السمنة في Houston، TX
43 دراسات لـ السمنة تبحث عن مشاركين في مواقع داخل وحول Houston (ضمن نطاق 30 ميلًا تقريبًا). افتح الدراسة لمعرفة من يمكنه المشاركة وكيفية التواصل مع فريق الدراسة.
النص الرسمي للدراسة (بالإنجليزية)
تبحث عن مشاركين لدراسة؟ أبرزها في أعلى الصفحة — $99 لمدة 30 يومًا →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
جارٍ التسجيلالمرحلة 2
- Juno Research /ID# 282413, Houston
- PlanIt Research /ID# 282204, Houston
- JCCT - Juno Bellaire /ID# 282263, Bellaire · على بُعد 7 ميل
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
جارٍ التسجيلالمرحلة 2
- Cardiovascular Specialists of Willowbrook, Houston
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
جارٍ التسجيلالمرحلة 3
- PlanIt Research, PLLC, Houston
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
جارٍ التسجيلالمرحلة 3
- DM Clinical, Houston
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
جارٍ التسجيلالمرحلة 3
- Houston Research Institute, Houston
- The Endocrine Center, Houston
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
جارٍ التسجيلالمرحلة 3
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
جارٍ التسجيلالمرحلة 3
- Research Site, Houston
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
جارٍ التسجيلالمرحلة 3
- McGovern Medical School, Houston
- Texas Childrens Hospital, Houston
- Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
- و 1 أخرى
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
جارٍ التسجيلالمرحلة 3
- Juno Research, Houston
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
جارٍ التسجيلالمرحلة 3
- Juno Research, Houston
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
جارٍ التسجيلالمرحلة 3
- Research Site, Houston
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
جارٍ التسجيلالمرحلة 3
- Biopharma Informatic, LLC, Houston
- Cardiovascular Specialists of Willowbrook, Houston
- PlanIt Research, PLLC, Houston
- و 2 أخرى
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
جارٍ التسجيلالمرحلة 3
- The University of Texas Health Science Center at Houston, Bellaire · على بُعد 7 ميل
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
جارٍ التسجيلالمرحلة 3
- Care Access - Houston, Houston
- JCCT - Juno Bellaire Site, Bellaire · على بُعد 7 ميل
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
جارٍ التسجيلالمرحلة 2
- PlanIt Research, PLLC, Houston
Semaglutide for Post-Smoking Cessation Weight Management
جارٍ التسجيلالمرحلة 2مرحباً بالمتطوعين الأصحاء
- The University of Texas Health Science Center at Houston, Houston
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
جارٍ التسجيلالمرحلة 3
- AURORA-2 Clinical Site, Houston
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
جارٍ التسجيلالمرحلة 3
- East Texas Cardiology PA, Houston
- Biopharma Informatic, Houston
- Orion Medical, Houston
- و 3 أخرى
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
جارٍ التسجيلالمرحلة 3
- HRI ? Medical Center, LLC, Houston
- Juno Research, LLC, Houston
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
جارٍ التسجيلالمرحلة 2
- Juno Research, Houston
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
جارٍ التسجيلالمرحلة 3
- Elevate Clinical, Houston
- Houston Research Institute, Houston
- Bellaire Clinical Research, LLC, Bellaire · على بُعد 7 ميل
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
جارٍ التسجيلالمرحلة 3
- Houston Pulm Med Res Network, Houston
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
جارٍ التسجيلالمرحلة 3مرحباً بالمتطوعين الأصحاء
- ACCOMPLISH-2 Research Site, Houston
- ACCOMPLISH-2 Research Site, Houston
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
جارٍ التسجيلالمرحلة 3
- Houston Pulm Med Res Network, Houston
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
جارٍ التسجيلالمرحلة 2
- PlanIt Research, PLLC, Houston
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
جارٍ التسجيلالمرحلة 2
- Biopharma Informatic, LLC, Houston
- PlanIt Research, PLLC, Houston
- Research Physicians Network, LLC, Houston
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
جارٍ التسجيلالمرحلة 4
- Center for Clinical Studies, Houston
- Bellaire Dermatology Associates, Bellaire · على بُعد 7 ميل
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
جارٍ التسجيلالمرحلة 3
- JCCT- Juno Northwest Houston, Houston
- Biopharma Informatic, LLC, Houston
- Johnson County Clinical Trials Juno Bellaire, Bellaire · على بُعد 7 ميل
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
جارٍ التسجيلالمرحلة 3
- Kailera Clinical Site, Bellaire · على بُعد 7 ميل
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
جارٍ التسجيلالمرحلة 3
- JCCT- Juno Northwest Houston, Houston
- Johnson County Clinical Trials Juno Bellaire, Bellaire · على بُعد 7 ميل
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
جارٍ التسجيلالمرحلة 3
- Biopharma Informatic, LLC, Houston
- Research Physicians Network, LLC, Houston
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
جارٍ التسجيلالمرحلة 3
- Research Site, Houston
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
جارٍ التسجيلالمرحلة 2
- Baylor Texas Children's Hospital, Houston
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
جارٍ التسجيلالمرحلة 3
- East Texas Cardiology PA, Houston
- Victorium Clinical Research, Houston
- Main Heart Clinic, Houston
- و 1 أخرى
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
جارٍ التسجيلالمرحلة 3
- ACCOMPLISH-1 Research Site, Houston
- ACCOMPLISH-1 Research Site, Houston
PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents
جارٍ التسجيلمرحباً بالمتطوعين الأصحاء
- Children's Nutrition Research Center, Houston
Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
جارٍ التسجيلمرحباً بالمتطوعين الأصحاءيشير إلى مدفوعات للمشاركين
- USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston
Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- Lilli Health, Houston
Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery
جارٍ التسجيل
- M D Anderson Cancer Center, Houston
Incretin Microdosing for Cardiometabolic Health in People With HIV
جارٍ التسجيلالمرحلة 2
- The University of Texas Health Science Center at Houston, Houston
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
جارٍ التسجيلالمرحلة 2
- Baylor College of Medicine, Houston
RESET System Pivotal Trial (Rev F)
جارٍ التسجيل
- Baylor College of Medicine, Houston
Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity
جارٍ التسجيل
- Houston Methodist Hospital, Houston
تجارب السمنة في مدن أخرى
- Chicago, IL41 دراسات
- New York City, NY40 دراسات
- San Antonio, TX40 دراسات
- Washington, DC33 دراسات
- Orlando, FL31 دراسات
- Dallas, TX30 دراسات
- Boston, MA28 دراسات
- Las Vegas, NV27 دراسات
- Miami, FL27 دراسات
- Baltimore, MD25 دراسات
- Jacksonville, FL25 دراسات
- St. Louis, MO25 دراسات
دراسات أخرى في Houston
- سرطان الرئة غير صغير الخلايا145 دراسات
- سرطان الثدي126 دراسات
- السرطان (جميع الأنواع)121 دراسات
- السرطان النقيلي104 دراسات
- سرطان القولون والمستقيم102 دراسات
- سرطان المبيض89 دراسات
- ابيضاض الدم النقوي الحاد85 دراسات
- سرطان الرئة78 دراسات
- سرطان البروستاتا76 دراسات
- سرطان بطانة الرحم68 دراسات
- سرطان البنكرياس61 دراسات
- ميلانوما59 دراسات
من ClinicalTrials.gov، البيانات مستخرجة في 05/10/2026. كل دراسة تحدد معايير أهليتها الخاصة؛ فريق الدراسة هو من يحدد من يمكنه المشاركة.